Target intelligence / Profile preview

RPL36A-HNRNPH2 readthrough (RPL36A-HNRNPH2)

Target
RPL36A-HNRNPH2
Molecular classification
Ribosomal protein, Structural constituent of ribosome, Readthrough protein (product of transcriptional readthrough between two adjacent loci)
01

Overview

RPL36A-HNRNPH2 readthrough is a locus on chromosome X formed by natural read-through transcription between the adjacent genes encoding ribosomal protein L36a and heterogeneous nuclear ribonucleoprotein H2[4][5]. The resulting transcript produces a protein similar to RPL36A, a ribosomal structural protein involved in protein synthesis[2][4][5]. Alternatively spliced transcript variants exist. The locus is implicated as a genomic region associated with Fabry disease and intellectual developmental disorder, though no evidence exists for direct drug targeting or receptor activity[1][5]. Regulatory elements in this region may affect the expression of disease-relevant neighboring genes such as *GLA* (alpha-galactosidase A)[1]. In summary, **RPL36A-HNRNPH2 readthrough** is best classified as a structural ribosomal protein from a readthrough locus with disease associations, but it does not conform to the usual categories of therapeutic drug targets, such as receptor, enzyme, or ion channel[1][2][4][5].

Other names
RPL36A-HNRNPH2 proteinRPL36A-HNRNPH2 geneRibosomal protein L36a-Heterogeneous nuclear ribonucleoprotein H2 readthroughH0Y3V9 protein (UniProt accession)H7BZ11 protein (UniProt accession)
02

Biological functions

Structural constituent of ribosome (involved in ribosome assembly and function, supporting protein synthesis)
03

Disease associations

Fabry disease (associated locus, regulatory involvement but not direct causative protein)Intellectual developmental disorder, X-linked, syndromic Bain type (as part of locus)

Beyond the preview

Go deeper on RPL36A-HNRNPH2 readthrough (RPL36A-HNRNPH2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RPL36A-HNRNPH2 readthrough (RPL36A-HNRNPH2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call